Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 376 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22114500T>A |
| Variant | c.1216T>A |
| Variant Start Position | 1216 |
| Location | Exon 11 |
| Amino Acid Change | p.Cys406Ser |
| ACMG Call | - |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Likely Pathogenic | Effect Type | Missense |
| Variant Type | SNV |
| PMID | 30682568, 24756041 |
| Article Count | 2 |
| Times Observed | < 3 |
| Clinical Phenotype | - |
| ACMG Categories | pm2, pm5, pp3, ppc |
| ACMG Explanations | pm2: chrX:22132619 ref:G alt:C was not found in gnomAD exomes or genomes. chrX:22132618 ref:T alt:A was not found in gnomAD exomes or genomes. pm5: This is a missense variant at an amino acid residue where a different missense change has been established as pathogenic. pp3: The SIFT, MutationTaster, and PolyPhen predictions agree that this variant is possibly or probably damaging. |
| Variant in Clinvar | No |
| ClinVar Classification | - |
| Categories In Literature | ppc |
| No Contrary Evidence Found | Yes |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | - |
| GnomAD Alleles | - |
| DBNSFP Alleles | X-22132619-G-C X-22132618-T-A |
| Other Alleles | X-22132619-GT-CG X-22132619-GT-CC X-22132619-GT-CA X-22132618-TGT-AGC |
| Note | nan |
| Warnings | - |